Sponsor or institution
Clinical trials and research at Shanghai Institute Of Biological Products
As of November 12, 2026, Find a Trial lists 11 clinical trials run by Shanghai Institute Of Biological Products that are recruiting, in China. By phase: Phase 1 (8), Phase 2 (1), Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 1Country
Newest trials
All recruiting trials (11)
-
Influenza split vaccine for people aged 60 and older
This trial will test whether a split influenza vaccine is safe and triggers an immune response in people aged 60 and older compared with a different vaccine formulation and a placebo.
-
SIBP-A10 injection for adults with advanced malignant tumors
This trial will test whether SIBP-A10 injections are safe and tolerable and to identify the best dose for adults with advanced metastatic tumors.
-
SIBP-A16 injections in healthy adults to find safe doses and routes
This trial will test different doses and ways of giving SIBP-A16 to see if they are safe and how the body handles the drug in healthy adults.
-
SIBP-A19 injection for advanced solid tumors
This will test SIBP-A19 injection in adults with advanced solid tumors to find a safe dose and see side effects and how the drug behaves in the body.
-
SIBP-A18 injection for advanced malignant solid tumors
This will test whether SIBP-A18 injections are safe and can help adults with advanced solid tumors, including CLDN18.2-positive gastric, pancreatic, or biliary cancers.
-
Two-dose recombinant shingles vaccine for healthy adults 40 and older
This trial will try two doses of a recombinant shingles vaccine in healthy adults aged 40 and over to see how safe it is and whether it produces an immune response.
-
Two-dose MVA monkeypox live vaccine in adults
This trial will test whether two doses of an MVA-strain monkeypox live vaccine are safe and produce an immune response in adults, including healthy people, men who have sex with men, and people living with HIV.
-
Treatment of advanced solid tumors with SIBP-A17 injection
This study is testing a new injection called SIBP-A17 to see if it can safely help people with advanced solid tumors.
-
Using Peguricase with Methotrexate for Uncontrolled Gout
This study is testing if combining an injection of peguricase with methotrexate can help people with uncontrolled gout who haven't found relief with standard treatments.
-
Treatment of advanced malignant solid tumors with SIBP-A13 injection
This study is testing a new injection called SIBP-A13 to see if it can safely help people with advanced solid tumors and to find the best dose for treatment.
-
Treatment of advanced head and neck cancer with SIBP-03
This study is testing a new treatment called SIBP-03 for people with advanced head and neck cancer to see if it works better than a placebo and how safe it is.
Quick answers
How many clinical trials run by Shanghai Institute Of Biological Products are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 8, Phase 2: 1, Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.